Tenet Competitors

Stocks . USA . 
Stock . Tenet Healthcare
THC Stock  USD 189.49  0.09  0.05%   
Tenet Healthcare competes with SEI Investments, Demant AS, Coca Cola, Golub Capital, and First Trust; as well as few others. The company runs under Health Care Providers & Services sector within Health Care industry. Analyzing Tenet Healthcare competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Tenet Healthcare to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Tenet Healthcare Correlation with its peers.
For information on how to trade Tenet Stock refer to our How to Trade Tenet Stock guide.

Tenet Healthcare vs Oaktree Capital Correlation

Average diversification

The correlation between Tenet Healthcare and OAK-PB is 0.12 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Tenet Healthcare and OAK-PB in the same portfolio, assuming nothing else is changed.

Moving against Tenet Stock

  0.44NPTH NeuPath HealthPairCorr
  0.34CAH Cardinal Health Earnings Call This WeekPairCorr
  0.33EHAB EnhabitPairCorr
The current year's Return On Tangible Assets is expected to grow to 0.18. The current year's Return On Capital Employed is expected to grow to 0.29. At present, Tenet Healthcare's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 237.5 M, whereas Other Current Assets are forecasted to decline to about 823.6 M.
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
187.01189.24191.47
Details
Intrinsic
Valuation
LowRealHigh
170.54216.82219.05
Details
Naive
Forecast
LowNextHigh
175.98178.21180.44
Details
22 Analysts
Consensus
LowTargetHigh
216.28237.67263.81
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Tenet Healthcare. Your research has to be compared to or analyzed against Tenet Healthcare's peers to derive any actionable benefits. When done correctly, Tenet Healthcare's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Tenet Healthcare.

Tenet Healthcare Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Tenet Healthcare and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Tenet and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Tenet Healthcare does not affect the price movement of the other competitor.

High positive correlations

BWA
+ 0.91
SEIC
OAK-PB
+ 0.64
WILLF
CCHBF
+ 0.62
SEIC
OAK-PB
+ 0.58
ORIC
BWA
+ 0.56
CCHBF
ORIC
+ 0.54
WILLF
  

High negative correlations

ORIC
- 0.61
CCHBF
ORIC
- 0.46
SEIC
BWA
- 0.4
NFTY
BCRD
- 0.4
CCHBF
NFTY
- 0.39
CCHBF
BWA
- 0.33
ORIC

Risk-Adjusted Indicators

There is a big difference between Tenet Stock performing well and Tenet Healthcare Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Tenet Healthcare's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Cross Equities Net Income Analysis

Compare Tenet Healthcare and related stocks such as SEI Investments, Demant AS, and Coca Cola HBC Net Income Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
20102011201220132014201520162017201820192020202120222023202420252026
SEIC3.8 M205 M206.8 M288.1 M318.7 M331.7 M333.8 M404.4 M505.9 M501.4 M447.3 M546.6 M475.5 M462.3 M581.2 M668.4 M701.8 M
GBDC59 K31.8 M46.5 M65.4 M70.8 M69.2 M82.3 M82 M(18.6 M)54.9 M340.3 M153.4 M258.6 M273.8 M396.8 M456.3 M479.1 M
ORIC(22 M)(22 M)(22 M)(22 M)(22 M)(22 M)(22 M)(22 M)(21.4 M)(26.9 M)(73.7 M)(77.7 M)(89.1 M)(100.7 M)(127.8 M)(115.1 M)(109.3 M)
BWA(12.1 M)550.1 M500.9 M624.3 M655.8 M609.7 M118.5 M439.9 M930.7 M746 M500 M537 M944 M625 M338 M388.7 M335.4 M

Tenet Healthcare and related stocks such as SEI Investments, Demant AS, and Coca Cola HBC Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Tenet Healthcare financial statement analysis. It represents the amount of money remaining after all of Tenet Healthcare operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Tenet Healthcare Competitive Analysis

The better you understand Tenet Healthcare competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Tenet Healthcare's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Tenet Healthcare's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
THC SEIC WILLF CCHBF GBDC NFTY ORIC BCRD BWA OAK-PB
 0.05 
 189.49 
Tenet
 2.25 
 88.04 
SEI
 2.50 
 36.53 
Demant
 0.00 
 51.60 
Coca
 0.07 
 13.55 
Golub
 0.04 
 56.10 
First
 2.00 
 10.76 
Oric
 0.66 
 7.50 
Blueone
 1.35 
 48.93 
BorgWarner
 1.12 
 21.61 
Oaktree
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Somewhat reliable
Dangerous
Very steady
Very steady
Market Performance
(90 Days Performance)
Weakest
Fair
Good
Fair
Weakest
Weakest
Weakest
Soft
Fair
Soft
Odds of Financial Distress
(Probability Of Bankruptcy)
Tiny
Tiny
Low
Small
Low
Low
High
High
Tiny
Low
Current Valuation
(Equity Enterprise Value)
Under Valued
Over Valued
Over Valued
Fairly Valued
Under Valued
Fairly Valued
Under Valued
Over Valued
Under Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Strong Buy
Buy
Not Available
Not Available
Buy
Not Available
Strong Buy
Not Available
Strong Buy
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Hold
Strong Buy
Sell
Cautious Hold
Hold
Strong Hold
Cautious Hold
Strong Sell
Strong Hold
Cautious Hold
Current Ratio
1.4
4.43
0.78
1.02
3.33
N/A
18.72
1.32
1.72
N/A
Net Asset
28.94 B
2.68 B
29.86 B
8.51 B
8.98 B
43.42 M
274.14 M
447.11 K
13.99 B
14.4 M
Profit Margin
0.065
0.31
0.11
N/A
0.43
N/A
N/A
N/A
0.0095
N/A
EBITDA
6.89 B
822.55 M
4.3 B
1.13 B
1.09 M
N/A
(126.74 M)
(485.88 K)
1.32 B
1.01 B
Operating Margin
0.15
0.28
0.16
N/A
0.79
N/A
N/A
-15.48
0.0841
N/A
Current Valuation
26.87 B
9.57 B
7.98 B
10.17 B
8.45 B
N/A
785.5 M
84.72 M
12.25 B
N/A
Price To Book
4.15
4.32
5.49
2.9
0.9
N/A
2.63
495.8
1.73
N/A
Retained Earnings
3.01 B
758 M
N/A
2.9 B
(48.82 M)
N/A
(562.77 M)
N/A
6.41 B
N/A
Current Asset
3.38 B
1 B
N/A
2.51 B
N/A
N/A
N/A
N/A
838.3 M
N/A
Five Year Return
N/A
1.18
N/A
N/A
7.8
8.5
N/A
N/A
1.67
N/A
One Year Return
N/A
N/A
N/A
N/A
N/A
1.9
N/A
N/A
N/A
N/A
Beta
1.41
0.97
0.93
0.93
0.44
0.49
1.36
1.15
1.05
N/A
Number Of Employees
74.48 K
5.07 K
20.57 K
33 K
N/A
646
106
1
38.3 K
N/A
Equity Positions Weight
N/A
N/A
N/A
N/A
N/A
99.41
N/A
N/A
N/A
N/A
Shares Outstanding
87.89 M
122.44 M
223.18 M
366.73 M
266.01 M
N/A
97.39 M
10.34 M
213.93 M
N/A
Three Year Return
N/A
N/A
N/A
N/A
N/A
8.6
N/A
N/A
N/A
N/A
Cash Flow From Operations
2.05 B
622.34 M
2.62 B
1.14 B
(113.59 M)
N/A
(112.66 M)
(452.47 K)
1.35 B
(2.73 B)
Annual Yield
N/A
0.0117
N/A
0.0299
0.12
N/A
N/A
N/A
0.0141
0.0363
Total Debt
14.33 B
32.13 M
6.1 B
2.45 B
4.9 B
N/A
3.18 M
43.76 K
4.34 B
7.82 B
Return On Equity
0.27
0.29
0.28
0.16
0.0942
N/A
-0.4
-5.96
0.0304
N/A
Z Score
N/A
N/A
0.6
1.8
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
0.0775
0.14
0.071
0.0599
0.0486
N/A
-0.25
-1.01
0.0544
N/A
Number Of Shares Shorted
2.72 M
1.49 M
N/A
N/A
5.58 M
N/A
21.14 M
N/A
11.62 M
N/A
Book Value Per Share
45.68
19.58
38.36
8.95
14.97
N/A
4.18
-0.003
28.0
N/A
Current Liabilities
2.55 B
224.48 M
N/A
2.61 B
N/A
N/A
N/A
N/A
484 M
N/A
Total Asset
28.94 B
2.68 B
29.86 B
8.51 B
8.98 B
43.42 M
274.14 M
447.11 K
13.99 B
14.4 M
Debt To Equity
3.3
0.015
1.64
1.02
1.21
N/A
0.054
0.35
0.59
N/A
Short Ratio
3.48
2.45
N/A
N/A
2.68
N/A
12.1
N/A
3.18
N/A
Target Price
237.67
98.83
N/A
N/A
15.0
N/A
21.0
N/A
50.54
N/A
Last Dividend Paid
N/A
0.98
N/A
N/A
1.56
0.13
N/A
N/A
0.5
2.97
Shares Owned By Institutions
98.5
74.4
18.48
28.5
46.53
N/A
93.29
N/A
99.01
N/A
Market Capitalization
16.74 B
10.64 B
7.02 B
8.93 B
3.61 B
N/A
1.07 B
87.86 M
10.45 B
6.1 B
Price To Earning
11.95
19.7
36.39
17.76
21.96
N/A
N/A
N/A
17.95
12.69
Price To Earnings To Growth
0.85
1.4
1.75
N/A
1.51
N/A
N/A
N/A
1.21
N/A
Price To Sales
0.8
4.74
0.33
1.1
4.14
N/A
N/A
1675.06
0.74
N/A
Net Income
4.06 B
581.19 M
2.08 B
547.2 M
376.65 M
N/A
(127.85 M)
(530.83 K)
367 M
1.16 B
Earnings Per Share
14.71
5.63
1.45
1.47
1.42
N/A
-1.71
-0.051
0.71
N/A
Shares Owned By Insiders
0.7
16.76
60.87
46.89
1.37
N/A
6.71
87.07
0.99
N/A
Revenue
20.66 B
2.13 B
19.7 B
7.17 B
802.73 M
N/A
N/A
72.2 K
14.08 B
1.45 B
Working Capital
3.37 B
1.17 B
N/A
(106 M)
N/A
N/A
237.4 M
N/A
2.88 B
N/A
Ten Year Return
N/A
N/A
N/A
N/A
N/A
10.3
N/A
N/A
N/A
N/A
Cash And Equivalents
3.02 B
791.44 M
1.24 B
1.77 B
85.2 M
N/A
227.06 M
167.13 K
2.09 B
N/A
Cash Per Share
11.19
5.87
5.46
4.84
0.5
N/A
5.74
0.02
5.27
N/A
Gross Profit
8.56 B
1.77 B
14.67 B
3.14 B
870.78 M
N/A
N/A
17.42 K
2.6 B
601.12 M
Day Typical Price
189.49
87.39
36.53
51.6
13.62
56.1
11.21
7.5
48.71
21.49
Accumulation Distribution
N/A
0.022
N/A
N/A
0.0196
N/A
0.11
N/A
0.0133
324.8
Market Facilitation Index
N/A
1.94
N/A
N/A
0.27
N/A
1.36
N/A
0.65
0.0
Daily Balance Of Power
0
1.0
9.2 T
0.0
0.037
0
(0.16)
0
1.0
0.5854
Period Momentum Indicator
(0.09)
1.94
0.89
N/A
0.01
(0.02)
(0.22)
(0.05)
0.65
0.24
Rate Of Daily Change
1.0
1.02
1.02
1.0
1.0
1.0
0.98
0.99
1.01
1.01
Day Median Price
189.49
87.07
36.53
51.6
13.66
56.1
11.44
7.5
48.61
21.44
Price Action Indicator
(0.04)
1.94
0.45
N/A
(0.10)
(0.01)
(0.79)
(0.03)
0.65
0.29
Relative Strength Index
43.07
59.24
83.83
73.31
47.28
40.9
50.36
46.71
60.94
61.24
Coefficient Of Variation
(1,735)
1013.34
(34,770)
800.76
(4,054)
(999.54)
(3,357)
1892.3
941.76
3236.72
Mean Deviation
1.46
0.9576
0.4268
0.5302
0.702
0.5583
2.81
4.9
1.23
0.5418
Jensen Alpha
(0.19)
0.0605
(0)
0.1683
(0.04)
(0.1)
(0.14)
1.26
0.1081
0.0104
Total Risk Alpha
(0.31)
0.026
(0.11)
0.0639
(0.09)
(0.13)
(0.40)
(0.34)
0.0509
(0.04)
Sortino Ratio
N/A
0.0548
N/A
N/A
N/A
N/A
N/A
0.057
0.0724
(0.05)
Downside Variance
N/A
1.43
N/A
N/A
N/A
N/A
N/A
258.41
2.78
0.6127
Standard Deviation
2.3
1.28
1.38
1.36
0.8799
0.7051
3.84
18.51
1.71
0.7841
Kurtosis
10.5
2.07
27.37
13.13
0.1217
0.4636
1.49
49.39
1.32
5.02
Potential Upside
3.14
2.1
2.32
3.2
1.37
0.8215
6.63
2.41
3.51
1.34
Treynor Ratio
(0.16)
0.1065
0.0768
(1.01)
(0.13)
(0.25)
(0.32)
(0.17)
0.1381
0.1922
Maximum Drawdown
14.8
7.41
8.87
11.95
3.53
3.79
15.34
187.41
8.11
4.82
Variance
5.31
1.65
1.89
1.86
0.7743
0.4972
14.77
342.53
2.94
0.6148
Market Risk Adjusted Performance
(0.15)
0.1165
0.0868
(1.00)
(0.12)
(0.24)
(0.31)
(0.16)
0.1481
0.2022
Risk Adjusted Performance
(0.03)
0.076
0.0026
0.0953
(0.02)
(0.07)
(0.01)
0.048
0.0829
0.0232
Skewness
1.94
0.4261
(3.73)
1.06
0.0534
(0.12)
0.5166
6.21
0.0107
(0.90)
Semi Deviation
N/A
1.08
N/A
N/A
N/A
N/A
N/A
7.12
1.55
0.7552
Information Ratio
(0.08)
0.051
(0.05)
0.0799
(0.09)
(0.19)
(0.05)
0.0495
0.0704
(0.05)
Value At Risk
(3.00)
(1.49)
(1.28)
N/A
(1.31)
(0.99)
(4.48)
(8.76)
(2.90)
(0.99)
Expected Short fall
N/A
(1.03)
N/A
N/A
N/A
N/A
N/A
(12.38)
(1.34)
(0.62)
Downside Deviation
N/A
1.2
N/A
N/A
N/A
N/A
N/A
16.08
1.67
0.7828
Semi Variance
N/A
1.17
N/A
N/A
N/A
N/A
N/A
50.71
2.41
0.5703

Tenet Healthcare Competition Performance Charts

Five steps to successful analysis of Tenet Healthcare Competition

Tenet Healthcare's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Tenet Healthcare in relation to its competition. Tenet Healthcare's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Tenet Healthcare in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Tenet Healthcare's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Tenet Healthcare, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Tenet Healthcare position

In addition to having Tenet Healthcare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Gold and Gold Mining Thematic Idea Now

Gold and Gold Mining
Gold and Gold Mining Theme
Large and mid-size companies, ETFs and funds that are either investing, exploring or producing, gold or indirectly involved in trading or making gold products. The Gold and Gold Mining theme has 67 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Gold and Gold Mining Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Tenet Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tenet Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tenet Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tenet Healthcare Stock:
How To Invest In Tenet
Details
Is Tenet Stock a good investment?
Details
What is Tenet Healthcare's Net Worth?
Details
Largest Health Care Providers & Services Companies
View
Largest Health Care Equipment & Services Companies
View
Check out Tenet Healthcare Correlation with its peers.
For information on how to trade Tenet Stock refer to our How to Trade Tenet Stock guide.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Will Health Care Providers & Services sector continue expanding? Could Tenet diversify its offerings? Factors like these will boost the valuation of Tenet Healthcare. If investors know Tenet will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Tenet Healthcare data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0.21)
Earnings Share
14.71
Revenue Per Share
226.324
Quarterly Revenue Growth
0.032
Return On Assets
0.0775
The market value of Tenet Healthcare is measured differently than its book value, which is the value of Tenet that is recorded on the company's balance sheet. Investors also form their own opinion of Tenet Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tenet Healthcare's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Tenet Healthcare's market value can be influenced by many factors that don't directly affect Tenet Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Tenet Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tenet Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Tenet Healthcare's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY